Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma. Sci Adv. 2022 10 07; 8(40):eabo8043.
View in:
PubMed
subject areas
Animals
Carcinogens
Carcinoma, Transitional Cell
Cell Line, Tumor
Enhancer of Zeste Homolog 2 Protein
Mice
Urinary Bladder Neoplasms
authors with profiles
Andrea Piunti